News for Equillium, Inc. (0A4D.L)

Equillium Inc. (EQ) recently encountered a significant hurdle as the U.S. Food and Drug Administration (FDA) decided against an accelerated approval pathway for

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat se

Equillium Inc. (EQ) recently received feedback from the U.S. Food and Drug Administration (FDA) regarding its efforts to fast-track the approval of itolizumab,

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 90 points on Thursday. The Dow traded down 0.23% to 42,358.68 while th...

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday. Following the market opening Thursday, the Dow trade...

Equillium CFO Jason Keyes sells $6,500 in stock

Equillium stock touches 52-week low at $0.6 amid market challenges

Equillium (EQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Equillium shares downgraded to hold from buy

Shares of Carvana Co. CVNA rose in today's pre-market trading after the company reported better-than-expected third-quarter financial results. Carvana reported...

Christine Zedelmayer, Sr. Vice President and Chief Operating Officer of Equillium Inc (EQ), executed a sale of 15,000 shares of the company on October 28, 2024.

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium CFO Jason Keyes sells $8,100 in company stock

Equillium executive sells $32,985 in stock

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide therapyEquillium...

Loading... Loading... Shares of Core & Main Inc CNM fell sharply during Tuesday's session after the company reported mixed first-quarter financial results. Co...

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management Under Bradbury’s leadership as CEO, Amylin...

IRCTC, SBI, Poonawalla Fincorp, JB Pharma, Glenmark Pharma, AstraZeneca, VRL Logistics, Power Grid, PTC India, Thermax, Wipro, Tata Motors, Biocon, IDBI Bank, ZEE, NTPC, Kamat Hotels, Indian Metals & Ferro Alloys, Shriram Properties